期刊名称：BIOORGANIC & MEDICINAL CHEMISTRY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
Bioorganic & Medicinal Chemistry is a Tetrahedron Publication for the Rapid Dissemination of Full Original Research Papers and Critical Reviews on Bioorganic Chemistry, Medicinal Chemistry, Bioinorganic Chemistry and Related Disciplines. The journal aims to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents. |
|
Instructions to Authors
Bioorganic & Medicinal Chemistry seeks to publish review articles and experimental or theoretical research results of outstanding significance and timeliness in the fields of bioorganic chemistry, medicinal chemistry, bioinorganic chemistry, and related disciplines.
Journal Policy: Publications will be typeset. The language of submission is English. All papers are submitted to referees who advise the Editor on the matter of acceptance in accordance with the high standards required, on the understanding that the subject matter has not been previously published and is not under consideration elsewhere. Referees will be asked to distinguish contributions meeting the above requirements and having an element of novelty, timeliness, and urgency that merits publication in the Journal. We ask referees to help in the selection of articles that have this breadth and suggest that papers covering narrower aspects of the field be sent to journals specializing in those areas. Referee names are not disclosed, but their views are forwarded by the Editor to the authors for consideration. Authors accept full responsibility for the factual accuracy of the data presented and should obtain any authorization necessary for publication. As such the contents of the papers are the sole responsibility of the authors and publication shall not imply the concurrence of the Editors or Publisher. Authors are encouraged to suggest names of several experts in the field when papers are first submitted or at any time in the evaluation process.
PREPARATION OF MANUSCRIPTS
Manuscripts should be printed, double line spaced, one side only, using black type on good quality white paper in a manner that ensures a clean, clear impression on the letters. The corresponding author's full mailing address, including mail codes, phone number, fax number, and e-mail address should be included. Authors are asked to provide four key words, which will be used for indexing purposes. The manuscript should be compiled in the following order: Graphical Abstract, Introduction, Results, Discussion, Conclusion, Experimental, References and Notes, Tables, Figures, Schemes, and Legends. Any author who is not fluent in idiomatic English are urged to gain assistance with manuscript preparation. Reviewers are not expected to correct grammatical errors and any deficiency in this area may detract from the scientific content of the paper.
Graphical Abstracts: Authors must supply a graphical abstract at the time the paper is first submitted. The abstract should summarize the contents of the paper in a concise, pictorial form designed to capture the attention of a wide readership and for compilation of databases. Carefully drawn chemical structures are desired that serve to illustrate the theme of the paper. An example can be found in the Journal.
Title: The title should be brief, specific, and rich in informative words. Capitalize the first letter of main words only.
Authors: After one line of space from the title, the authors' names and addresses should be provided on separate lines, centred on the width of the page. The author(s) to whom correspondence should be addressed by readers should be indicated with an asterisk. Use superscript a, b, c, to identify the address of each author when they differ.
Abstract: Authors must include a short abstract. With appropriate spacing this is placed immediately after the authors' address(es) and before the text. The abstract should state briefly the purpose of the research, the principal results, and major conclusion(s).
Articles: Articles should describe original research of high quality and timeliness. In the introductory section of the manuscript, the author should strive to define the significance of the work and the justification for its publication. Any background discussion should be brief and restricted to pertinent material. Following the Introduction the text should be arranged in the following order: Results, Discussion, Conclusion, and Experimental sections. Each section should be clearly marked with a separate, centred heading.
Reviews: These are specially-commissioned critical reviews of topical importance. Such articles are commissioned in appropriate fields. Authors wishing to submit a nonsolicited review article are requested to first contact Professor C.-H. Wong.
When submitting a review article, authors should submit biographical information for each author as well as a black and white photograph. It should be one paragraph (approximately 150B200 words) and should include: date and place of birth, universities attended, degrees obtained, principal professional posts held, present title, a line or two about the major research interests, and anything else professionally relevant that is of special interest.
Perspectives: In addition to the regular review article, the journal also publishes perspectives. These briefly review (in 1-4 printed pages) specific subjects which already have or are likely to have major impact in areas related to chemical biology and drug discovery. Authors of perspectives are those who have made the original contribution or have extended the original research to new breakthroughs. Perspectives are generally specially commissioned by the Editors, however, suggestions for topics and authors are welcomed. Individuals interested in contributing should contact the Editor-in-Chief, Prof. C.-H. Wong.
Symposia-in-Print: These comprise collections of original research papers (including experimental sections) covering specific topics. Topics for forthcoming symposia are announced in the Journal from time to time. A Guest Editor will invite authors active in the field to submit papers, which are then reviewed and processed for publication by the Guest Editor under the usual refereeing system. Opportunity is also provided for other active investigators to submit contributions.
Acknowledgment: An acknowledgment section may be included, it should be placed after the manuscript text and before the references.
References and Notes: References to the literature must follow the format outlined for ACS publications (Journal of the American Chemistry Society style). Titles of journals are abbreviated according to Chemical Abstracts Service Source Index. For a detailed listing of journal abbreviations and citation formats, see: The ACS Style Guide; American Chemical Society: Washington, DC, 1986. References should be numbered consecutively as they appear throughout the text, and be indicated consecutively in the text with unparenthesized superscript numbers. Authors are expected to check the original source reference for accuracy. When references concerning related work by the author are quoted and such work is not available to the referee because it is "in press" or has been submitted to this or other journals, three copies of such work should be submitted with the manuscript for use by the referees and the editor. Reference to unpublished work is not acceptable, although reference to personal communications is.
Scientific Articles:
1. Barton, D. H. R.; Yadav-Bhatnagar, N.; Finet, J.-P.; Khamsi, J. Tetrahedron Lett. 1987, 28, 3111.
Books:
2. Doe, J. S.; Smith, J. In Medicinal Chemistry; Roe, P., Ed.; Pergamon Press: Oxford, 1990; Vol. 1, pp. 301-383.
Patent/Chem Abstract:
3. Lyle, F.R. U.S. Patent 6,973,257, 1995; Chem. Abstr. 1995, 123, 2870.
Meeting Abstact:
4.Prasad, A.; Jackson, P. Abstracts of Papers, Part 2, 212th National Meeting of the American Chemical Society, Orlando, FL, Aug 25-29, 1996; American Chemical Society: Washington, DC, 1996; PMSE 189.
Black & White or Color Photographs: High quality glossy prints of black and white photographs (i.e., high contrast gels) can be directly reproduced with inclusion in the manuscript. These should be submitted as originals with each of the original and review copies of manuscripts at the time of submission. Photocopies of such gels are unacceptable.
A limited number of color figures/photographs may be published in the journal at no expense to the author. The criterion for accepting the inclusion of a color figure will be that it must contribute to the scientific and informational content of the published work. Manuscripts with color figures should be submitted with original glossy photographs on all copies of the manuscript. Black and white photocopies of color figures are unacceptable although high quality color copies of color photographs and original figures printed from high-resolution color printers are acceptable for the reviewers copies. Photographs should be submitted in the actual size that is appropriate for either one- or two-column format (8.4- or 17.7-cm width, respectively)
Artwork: Figures, schemes and equations must be cited in the text and numbered in order of appearance with Arabic numerals. Other graphics, such as structures, do not need to be numbered, but please indicate in the text where these are to appear. All graphics (including chemical structures) must be provided at the actual size that they are to appear (single-column width is 8.4 cm, double-column width is 17.7 cm). Please arrange schematics so that they fill the column space (either single or double), so as not to leave a lot of unused white space. Please ensure that all illustrations within a paper are consistent in type, quality and size. Captions should not be included as part of the graphic; instead all captions should be supplied at the end of the text. Reagents and conditions (unless incorporated into the actual schematic) should also be labelled with the figure or scheme number, and the corresponding author's name.
To help author's provide actual size graphics, it is suggested that the following settings be used with CSC ChemDrawTM and ISIS DRAWTM: font 10 pt Helvetica, chain angle 120 , bond spacing 18% of length, fixed length 14.4 pt (0.508 cm), bold width 2.0 pt (0.071 cm), line width 0.6 pt (0.021 cm), margin width 1.6 pt (0.056 cm), and hash spacing 2.5 pt (0.888 cm). Compound numbers should be in boldface. With these settings, to ensure a proper size, the graphic must be printed at 70%. In order to accurately design schematics to print out at the proper width with the reduction, the original drawing cannot exceed a column width of 12.0 cm (for single column) and 25.0 cm (for double column). To produce a double column width landscape mode will need to be used. Layout design is facilitated if authors submit their original artwork in the actual size to be published. Please save graphics as an Encapsulated PostScript file (EPS) or a Tagged Image File Format (TIFF), as well as the program the graphic was originally drawn in. For more details on the preparation and submission of artwork, please visit http://www.authors.elsevier.com
Tables: All tables must have a title appearing at the top. Column headings should be as brief as possible, using abbreviations when necessary. Columns should contain one or two entries only. Do not use vertical lines. Indicate placement of all tables at the relevant point in the text. Tables must be numbered in order of appearance with Arabic numerals. Footnotes to tables should be given letter designations and cited in the table with a superscript letter. The sequence of letters should proceed by line rather than by column. If a footnote is cited both in the text and in a table, insert a lettered footnote in the table to refer to the footnote in the text. Each table should be provided with a descriptive heading, which, together with the individual column headings, should make the table, as nearly as possible, self-explanatory. In setting up tabulations, authors are requested to keep in mind the column widths (8.4 cm and 17.7 cm), and to make the table conform to the limitations of these dimensions.
Experimental Section: Authors should be as concise as possible in experimental descriptions. The experimental section must contain all the information necessary to guarantee reproducibility. An introductory paragraph containing information concerning solvents, sources of less common starting materials, special equipment, etc. should be provided. The procedures should be written in the past tense and include the weight, mmol, volume, etc. in brackets after the names of the substances or solvents. General reaction conditions should be given only once. The title of an experiment should include the chemical name and compound number of the product prepared; subsequently, this compound should be identified by its number. Details of the workup procedure must be included. Physical and spectroscopic data, including NMR, high-resolution mass analysis, and elemental analysis can be included in the experimental section or presented in tables.
Biological Data: Biological test methods must be referenced or described in sufficient detail to permit the experiments to be repeated by others. Standard compounds and established drugs/agents should be tested in the same system for comparison. Statistical limits (statistical significance) for the biological data are usually required. If statistical limits cannot be provided, the number of determinations and an indication of the variability and reliability of the results should be given. References to statistical methods of calculation should be included. Doses and concentrations should be expressed in molar quantities when comparisons of potencies are made with compounds having substantial differences in molecular weights. For inactive agents, the highest concentration or dose level tested should be indicated. Detailed descriptions of biological methods should be placed in the Experimental section.
Structural Data: Atomic coordinates for structures of biological macromolecules determined by X-ray, NMR, or other methods should be deposited with the Protein Data Bank (PDB), Chemistry Department, Brookhaven National Laboratories, Upton, Long Island, New York 11973. It is the responsibility of the author to obtain a file name for the macromolecule; the file name must be referenced in the manuscript. Manuscripts will be sent out for review only after receiving a written statement from the author that the coordinates will be deposited. If a manuscript is accepted for publication, and the PDB file name has not yet been obtained, it must be added in the proof prior to publication. Upon written request by the author the PDB will refer requests for coordinates to the originating author,but one year after publication, they will be made generally available upon request. Please address all inquiries about depositing to the PDB.
Nomenclature: It is the responsibility of the authors to provide correct nomenclature. Chemical names for drugs are preferred. If these are not practical, generic names, names approved by the U.S. Adopted Names Council, or those approved by the World Health Organization may be used. If a generic name is used, its chemical name or structure should be provided at the point of first citation. Authors will find the following as useful reference books for recommended nomenclature.
IUPAC Nomenclature of Organic Chemistry; Rigaudy, J.; Klesney, S. P., Eds; Pergamon: Oxford, 1979.
Enzyme Nomenclature; Webb, E. C., Ed.; Academic Press; Orlando, 1984.
Biochemical Nomenclature and Related Documents; The Biochemistry Society; London, 1978.
The ACS Style Guide; Dodd, J. S., Ed.; American Chemical Society: Washington, DC, 1986.
Captions: Captions for figures and schemes should be grouped together separately
Trademarks: Authors are required to acknowledge trademark protection in the standard fashion (e.g. Selectride®) although not for words which have entered general usage (e.g. pyrex).
Hazardous Materials or Procedures: Authors are requested to draw attention to hazards by adding the word CAUTION followed by a brief descriptive phrase and literature references if appropriate.
Characterization of New Compounds: All new compounds should be fully characterized with relevant spectroscopic data. Microanalyses should be included whenever possible. Under appropriate circumstances, high resolution mass spectra may serve in lieu of microanalysis, if accompanied by suitable NMR criteria for sample homogeneity.
X-Ray Crystallographic Data: Prior to submission of the manuscript, the author should deposit crystallographic data for organic and metal-organic structures with the Cambridge Crystallographic Data Centre. The data, without structure factors, should be sent by e-mail to; deposit @ccdc.cam.ac.uk, as an ASCII file, preferably in CIF format. Hard copy data should be sent to CCDC, 12 Union Road, Cambridge, CB2 1EZ.
A checklist of data items for deposition can be obtained from the CCDC Home Page on the World Wide Web (http://www.ccdc.cam.ac.uk/) or by e-mail to: fileserv@ccdc.cam.ac.uk, with the one-line message, sendme checklist.
The data will be acknowledged, within three working days, with oneCCDC deposition number per structure deposited. These numbers should be included with the folowing standard text in the manuscript: Crystallographic data (excluding structure factors) for the structures in this paper have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication nos. CCDC........Copies if the data can be obtained, free of charge, on application to CCDC, 12 Union Road, Cambridge, CB2 1EZ, UK, (fax: +44- (0)1223-336033 or e-mail: deposit @ccdc.cam.ac.uk).
Deposited data may be accessed by the journal and checked as part of the refereeing process.
If data are revised prior to publication, a replacement file should be sent to CCDC.
Software: Software used as part of computer-aided drug/agent design (e.g. molecular modeling, QSAR, conformational analysis, molecular dynamics) should be readily available from accepted sources and the authors may specify where the software can be obtained. Assurance of the quality of the parameters employed for the relevant potential functions should be detailed in the manuscript.
Abbreviations: Standard ACS abbreviations should be used throughout the manuscript and are employed without periods. The preferred forms for some of the more commonly used abbreviations are mp, bp, C, K, min, h, mL, L, g, mg, g, cm, mm, nm, mol, mmol, mol, M, mM, M, ppm, HPLC, TLC, GC, 1H NMR, GC-MS, HRMS, FABHRMS, UV, IR, EPR, ESR, DNase, ED50, ID50, IC50, LD50, im, ip, iv, mRNA, RNase, rRNA, tRNA, cpm, Ci, dpm, Vmax, Km, k, t½. All nonstandard abbreviations should be defined following the first use of the abbreviation. For a detailed listing of standard abbreviations, see: The ACS Style Guide; American Chemical Society: Washington, DC, 1986.
Supplementary Material: Concise supplementary material may be provided for review purposes only. Supplementary material will be published only at the Editor's discretion.
Copyright guidelines: All authors must sign the "Transfer of Copyright" agreement before the article can be published. This transfer agreement enables Elsevier Science Ltd to protect the copyrighted material for the authors, but does not relinquish the author's proprietary rights. The copyright transfer covers the exclusive rights to reproduce and distribute the article, including reprints, photographic reproductions, microform, or any other reproductions of similar nature and translations, and includes the right to adapt the article for use in conjunction with computer systems and programs, including reproduction or publication in machine-readable form and incorporation into retrieval systems. Authors are responsible for obtaining from the copyright holder permission to reproduce any figures for which copyright exists.
Online Submission of Manuscripts Bioorganic & Medicinal Chemistry manuscripts can be submitted using the TetSubmit online submission and review environment. Authors are required to go to the website and upload their article and its associated artwork. A PDF is generated and the reviewing process is carried out using that PDF. All correspondence between editor and author is performed by e-mail. Authors are, however, legally obliged to sign and return a physical transfer of copyright form by conventional mail. To submit your paper online, please go to: http://www.tetsubmit.com.
Please ensure that the graphical abstract is included as page 1 of your manuscript when submitting online.
For detailed instructions on the preparation of electronic artwork, consult the Author Gateway from Elsevier Science at http://authors.elsevier.com
Templates are provided in order to allow authors to view their paper in a style close to the final printed form. Their use is optional.
All manuscripts will be fully typeset from the author's electronic files. It should be noted that due to defined typesetting standards and the complex requirements of electronic publishing, the Publisher will not always be able to exactly match the layout the author has submitted. In particular, in the finished journal article, figures and tables are usually placed at the top or bottom of pages. The template is only intended to be used in assisting with the preparation and submission of manuscripts.
It should be noted that use of the journal template is not a requirement and its adoption will neither speed nor delay publication. Elsevier can handle most major word processing packages and in general most formatting applied by authors for style and layout is replaced when the article is being typeset.
Mail Submission of Manuscripts: The original and three copies of the manuscript, including the graphical abstract and a signed and dated copyright transfer agreement form, should be sent to the appropriate editorial office, see below. In order to achieve the most rapid publication authors may wish to fax a copy (supplying their own telephone, fax and e-mail numbers) to the Editor at the time that they mail the manuscript. Authors may also submit their manuscripts by e-mail (contact the editorial office for details).
Manuscript Production from Diskette Files: To help expedite publication of manuscripts authors are asked to supply their revised manuscript versions both in hardcopy format and on diskette (text files, graphics and the graphical abstract). We can accept most word processor programs, in either Mac or DOS format. In all cases, also save the text as an ASCII file in case the word processing file is not translatable. It is important that the file on the disk and the printout are identical. Before sending your disk, please ensure that the following information is supplied: name of journal, name of author(s), name(s) of file(s) on disk, computer used (IBM or Mac), and the name and version of program used. Please save graphics as an Encapsulated PostScript file (EPS) or a Tagged Image File Format (TIFF), as well as the program the graphic was originally drawn in. All of the text and tabular material (if any) should be in a single file with the complete text first, followed by the tabular material. If tabular material is present, the column alignment should have been obtained with either the word-processing program's column utility or tabs or spaces, but not a mixture of these. When preparing the manuscript text, use a simple, full-width format with no page-formatting other than margin definitions. Do not include page numbers or other running material. Format the references as stated above. Ensure that all characters are correctly represented throughout the manuscript: for example, 1 (one) and 1 (ell), 0 (zero) and O (oh), x (ex) and x (times sign).
Submissions from Japan and other Asian countries:
Professor M. Shibasaki
Faculty of Pharmaceutical Sciences
University of Tokyo
7-3-1 Hongo, Bunkyo-ku
Tokyo 113
JAPAN
FAX: (81) 3 5684 5206
Telephone: (81) 3 3812 2111
E-mail: bmcbmcl@mol.f.u-tokyo.ac.jp
Submissions from Europe:
Professor H. Waldmann
Department of Chemical Biology
Max-Planck-Institut f¨¹r Moleculare Physiologie
Otto-Hahn-Strasse 11
44227 Dortmund
Germany
FAX: (49) 231 133 2499
Telephone: (49) 231 133 2400
E-mail: bmc@mpi-dortmund.mpg.de
All other submissions:
Professor Chi-Huey Wong
The Scripps Research Institute
Department of Chemistry, BCC 483A
10550 North Torrey Pines Road
La Jolla, California 92037
USA
FAX: (858) 784 7550 or (800) 410 1557 toll-free within the USA or Cananda
Telephone: (858) 784 7525
E-mail: bmc-bmcl@scripps.edu
Corrections: If there are errors of consequence in a published paper, a correction of the error should be sent to the Editor for publication in an "Additions and Corrections" section.
Proofs: Proofs will be despatched via e-mail by the Publisher and should be returned with corrections as quickly as possible, normally within 48 hours of receipt. Authors should ensure that corrections are returned in one communication and are complete, as subsequent corrections will not be possible. Any amendments will be incorporated and the final article will then be published online as an Article in Press on ScienceDirect www.sciencedirect.com.
Articles in Press take full advantage of the enhanced ScienceDirect functionality, including the ability to be cited. This is possible due the innovative use of the DO1 article identifier, which enables the citation of a paper before volume, issue and page numbers are allocated. The Article in Press will be removed once the paper has been assigned to an issue and the issue has been compiled.
Offprints: Any reprints required above the 25 offprints supplied free of charge must be indicated at the time of submission.
Page Charges: None.
Other Enquiries: Visit the Author Gateway from Elsevier Science at (http://authors.elsevier.com) for the facility to track accepted articles and set up e-mail alerts to inform you of when an article's status has changed. The Author Gateway also provides detailed artwork guidelines, copyright information, frequently asked questions and more.
Contact details for questions arising after acceptance of an article, especially those relating to proofs, are provided after registration of an article for publication
Editorial Board
|
Editor-in-Chief:
|
|
C.-H. Wong, The Scripps Research Institute, Department of Chemistry, BCC 483A, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
Fax: (1) 858 784 7550
Email:bmc-bmcl@scripps.edu
|
|
|
Japanese Regional Editor
|
|
M. Shibasaki, Graduate School of Pharmaceutical Sciences, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
Fax: (81) 3 5684 5206
|
C.-H. Wong, The Scripps Research Institute, Department of Chemistry, BCC 483A, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
Fax: (1) 858 784 7550
Email:bmc-bmcl@scripps.edu
|
|
|
|
|
|
|
|
European Regional Editor
|
|
H. Waldmann, Department of Chemical Biology, Max-Planck-Institut f¨¹r Molekulare Physiologie, Otto-Hahn-Strasse 11, 44227 Dortmund, Germany
Fax: (49) 231 133 2499
Email:bmc@mpi-dortmund.mpg.de
|
|
|
Chairman of the Executive Board of Editors for Tetrahedron Publications:
|
|
L. Ghosez, Laboratoire de Chimie Organique de Synth¨¨se, Universit¨¦ Catholique de Louvain, B-1348 Louvain-la-Neuve, Belgium
|
|
|
Editor Emeritus:
|
|
H.H. Wasserman, Chemistry Department, Yale University, PO Box 208107, New Haven, CT 06520-8107, USA
|
|
|
Executive Board of Editors:
|
|
D.L. Boger, Department of Chemistry, The Scripps Research Institute, La Jolla, CA 92037, USA
|
|
|
S.G. Davies, Dyson Perrins Laboratory, Oxford OX1 3QY, UK
|
|
|
B. Ganem, Department of Chemistry and Chemical Biology, Baker Laboratory, Cornell University, Ithaca, NY 14853-1301, USA
|
|
|
L. Ghosez, Laboratoire de Chimie Organique de Synth¨¨se, Universit¨¦ Catholique de Louvain, B-1348 Louvain-la-Neuve, Belgium
|
|
|
Lin Guo-Qiang, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 354 Fenglin Road, Shanghai 200032, PRC
|
|
|
S.F. Martin, Department of Chemistry and Biochemistry, University of Texas, Austin, TX 78712, USA
|
|
|
W.B. Motherwell, Department of Chemistry, University College, 20 Gordon Street, London WC1H 0AJ, UK
|
|
|
G. Ourisson, Centre National de la Recherche Scientifique, Centre de Neurochimie, 67084 Strasbourg, Cedex, France
|
|
|
G.H. Posner, Department of Chemistry, Johns Hopkins University, Baltimore, MD 21218, USA
|
|
|
M. Shibasaki, Graduate School of Pharmaceutical Sciences, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
|
|
|
T. Shioiri, Graduate School of Environmental and Human Sciences, Meijo University, Shiogamaguchi, Tempaku, Nagoya 468-8502, Japan
|
|
|
R.J.K. Taylor, Department of Chemistry, University of York, Heslington, YO10 5DD, UK
|
|
|
E.J. Thomas, Department of Chemistry, University of Manchester, Brunswick Street, Manchester M13 9PL, UK
|
H. Waldmann, Max-Planck-Inst. f¨¹r Molekular Physiology, Dept. of Chemical Biology, Otto-Hahn-Strasse 11, 44227 Dortmund, Germany
|
|
H.H. Wasserman, Department of Chemistry, Yale University, PO Box 208 107, New Haven, CT 06520-8107, USA
|
|
C.-H Wong, The Scripps Research Institute, Department of Chemistry, BCC 483A, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
|
|
Y. Yamamoto, Department of Chemistry, Graduate School of Science, Tohoku University, Sendai 980-8578, Japan
|
Editors of the Tetrahedron Organic Chemistry Series
|
|
J.E Baldwin, Dyson Perrins Laboratory, Oxford, OX1 3QY, UK
|
|
|
R.M Williams, Colorado State University, Fort Collins, USA
|
|
|
Board of Consulting Editors:
|
|
G.L. Grunewald, Lawrence, KS
|
|
P. Herrling, Basel
|
|
D. Hilvert, Zurich
|
|
D.C. Horwell, Norwich
|
|
J.R. Huff, West Point, PA
|
|
B. Imperiali, Cambridge, MA
|
|
K. Janda, La Jolla, CA
|
|
W.L. Jorgensen, New Haven, CT
|
|
A.R. Katritzsky, Gainesville, FL
|
|
P. Krogsgaard-Larsen, Copenhagen
|
|
R.A. Lerner, La Jolla, CA
|
|
S.J. Lippard, Cambridge, MA
|
|
H. Liu, Austin, TX
|
|
D. Mansuy, Paris
|
|
A. McKillop, Northumberland
|
|
B.W. Metcalf, King of Prussia, PA
|
|
R. Metternich, Berlin
|
|
S. Mignani, France
|
|
L.A. Mitscher, Lawrence, KS
|
|
W.H. Moos, San Diego, CA
|
|
K. Mori, Tokyo
|
K. Nakanishi, New York, NY
|
|
K.C. Nicolaou, La Jolla, CA
|
|
T. Ogawa, Saitama
|
|
H.L. Pearce, Indianapolis, IN
|
|
P. Potier, Gif-sur-Yvette
|
|
C.D. Poulter, Salt Lake City, UT
|
|
J. Rebek, Jr., La Jolla, CA
|
|
|
|
|
|
|
|
刊名字顺( Alphabetical List of Journals):
返回页首 